Meghan leads the Americas team for BP Ventures. Core areas of focus for the team include Upstream, Digital, Bio and Mobility. Meghan sits on the boards of Beyond Limits, Biosynthetic Technologies, and Advanced Biocatalytics Corporation. Previous board seats include Chromatin Inc., Taxon, Verdezyne, Xpansiv and Xact. Meghan has a PhD in bacterial genetics, post-doctoral work in plant genetics and an MBA focused on venture.